# D-Cycloserine for Serine Palmitoyltransferase Inhibition

> **NCT07542548** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 1 (actual)

## Conditions studied

- Hereditary Spastic Paraplegia

## Interventions

- **DRUG:** D-cycloserine

## Key facts

- **NCT ID:** NCT07542548
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-10
- **Primary completion:** 2026-03-17
- **Final completion:** 2026-03-17
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542548, "D-Cycloserine for Serine Palmitoyltransferase Inhibition". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07542548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*